Cargando…

An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease

OBJECTIVE: Prenatal exposures are known to alter fetal neurodevelopment and autonomic control. We aimed to explore the correlation between fetal autonomic activity, measured by fetal heart rate variability, and 18-month developmental outcome in subjects with congenital heart disease. STUDY DESIGN: F...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Saira, Fifer, William P., Ordonez-Retamar, Maria, Nugent, J. David, Williams, Ismée A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578909/
https://www.ncbi.nlm.nih.gov/pubmed/28471442
http://dx.doi.org/10.1038/jp.2017.59
_version_ 1783260601010618368
author Siddiqui, Saira
Fifer, William P.
Ordonez-Retamar, Maria
Nugent, J. David
Williams, Ismée A.
author_facet Siddiqui, Saira
Fifer, William P.
Ordonez-Retamar, Maria
Nugent, J. David
Williams, Ismée A.
author_sort Siddiqui, Saira
collection PubMed
description OBJECTIVE: Prenatal exposures are known to alter fetal neurodevelopment and autonomic control. We aimed to explore the correlation between fetal autonomic activity, measured by fetal heart rate variability, and 18-month developmental outcome in subjects with congenital heart disease. STUDY DESIGN: From 2010–2013, 5 fetuses with hypoplastic left heart syndrome, 9 with transposition of the great arteries, and 9 with tetralogy of Fallot were included in this prospective cohort study. A maternal abdominal fetal electrocardiogram monitor recorded fetal heart rate at 34–38 weeks gestational age. We assessed associations between fetal heart rate parameters including interquartile range and standard deviation of the fetal RR intervals and 18-month Bayley Scales of Infant Development III scores using Pearson’s correlation coefficient. Multivariable regression modeling identified predictors of neurodevelopmental scores. RESULTS: Fetal heart rate variability parameters at 34–38 weeks gestational age correlated with 18-month Cognition (r=0.47, p=0.03) and Motor scores (r=0.66, p=0.001). The interquartile range of the fetal RR intervals predicted Cognition (β=0.462, p=0.028, R(2)=0.282) and Motor (β=0.637, p<0.001, R(2)=0.542) scores. CONCLUSIONS: In fetuses with congenital heart disease, low heart rate variability at 34–38 weeks gestational age predicts diminished 18-month cognitive and motor performance. Prenatal autonomic activity may serve as a marker of early childhood development in these high-risk patients.
format Online
Article
Text
id pubmed-5578909
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-55789092017-11-04 An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease Siddiqui, Saira Fifer, William P. Ordonez-Retamar, Maria Nugent, J. David Williams, Ismée A. J Perinatol Article OBJECTIVE: Prenatal exposures are known to alter fetal neurodevelopment and autonomic control. We aimed to explore the correlation between fetal autonomic activity, measured by fetal heart rate variability, and 18-month developmental outcome in subjects with congenital heart disease. STUDY DESIGN: From 2010–2013, 5 fetuses with hypoplastic left heart syndrome, 9 with transposition of the great arteries, and 9 with tetralogy of Fallot were included in this prospective cohort study. A maternal abdominal fetal electrocardiogram monitor recorded fetal heart rate at 34–38 weeks gestational age. We assessed associations between fetal heart rate parameters including interquartile range and standard deviation of the fetal RR intervals and 18-month Bayley Scales of Infant Development III scores using Pearson’s correlation coefficient. Multivariable regression modeling identified predictors of neurodevelopmental scores. RESULTS: Fetal heart rate variability parameters at 34–38 weeks gestational age correlated with 18-month Cognition (r=0.47, p=0.03) and Motor scores (r=0.66, p=0.001). The interquartile range of the fetal RR intervals predicted Cognition (β=0.462, p=0.028, R(2)=0.282) and Motor (β=0.637, p<0.001, R(2)=0.542) scores. CONCLUSIONS: In fetuses with congenital heart disease, low heart rate variability at 34–38 weeks gestational age predicts diminished 18-month cognitive and motor performance. Prenatal autonomic activity may serve as a marker of early childhood development in these high-risk patients. 2017-05-04 2017-08 /pmc/articles/PMC5578909/ /pubmed/28471442 http://dx.doi.org/10.1038/jp.2017.59 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Siddiqui, Saira
Fifer, William P.
Ordonez-Retamar, Maria
Nugent, J. David
Williams, Ismée A.
An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title_full An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title_fullStr An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title_full_unstemmed An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title_short An antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
title_sort antenatal marker of neurodevelopmental outcomes in infants with congenital heart disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578909/
https://www.ncbi.nlm.nih.gov/pubmed/28471442
http://dx.doi.org/10.1038/jp.2017.59
work_keys_str_mv AT siddiquisaira anantenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT fiferwilliamp anantenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT ordonezretamarmaria anantenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT nugentjdavid anantenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT williamsismeea anantenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT siddiquisaira antenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT fiferwilliamp antenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT ordonezretamarmaria antenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT nugentjdavid antenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease
AT williamsismeea antenatalmarkerofneurodevelopmentaloutcomesininfantswithcongenitalheartdisease